December 27, 2018

WSJ Editorial Board: “False Claims Falsehoods”

The Wall Street Journal Editorial Board called on judges to “sanction the false claimers” who were responsible for the 11 False Claim Act (FCA) lawsuits that the U.S. Department of Justice (DOJ) asked to dismiss last week.

The DOJ said the company behind the suits, the National Health Care Analysis Group, was created for the “sole purpose” of filing copy-and-paste-style whistleblower lawsuits under the FCA by using false pretenses to find information on other companies. The group, which consisted of “investors and former Wall Street investment bankers,” retained what the Editorial Board called “trial-lawyer barons such as Mark Lanier” who “can smell money from the next solar system” to pursue the suits.

According to their filing, the DOJ said they spent 1,500 hours investigating the claims before seeking the dismissals.

Blog Law 360 Expert Analysis: "False Claims Act Proposal Is Unfair And Would Hinder Economic Growth" False Claims Act (FCA) U.S. Department of Justice building in Washington D.C. News Reuters "Has An Investor-Backed FCA Whistleblower Reached The End of the Road?" False Claims Act (FCA) U.S. Department of Justice building in Washington D.C. Blog Flying Blind: Secret Funding in Government Lawsuits and What to Do About It False Claims Act (FCA), Third Party Litigation Funding (TPLF) News On Appeal, Justice Dept. Prevails In Bid To Dismiss Pharma Fraud Case False Claims Act (FCA) ILR Briefly: TPLF in False Claims Act Cases Blog ILR Briefly: Third Party Litigation Funding In Qui Tam False Claims Act Cases False Claims Act (FCA), Third Party Litigation Funding (TPLF)
We Use Cookies to Make your Experience Better

What do we use cookies for?

We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. To learn more about cookies, including how to disable them, view our Cookie Policy. By clicking "I Accept" or "X" on this banner, or using our site, you consent to the use of cookies unless you have disabled them.